Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Crohn's Disease Forecast in 12 Major Markets to 2027: Focus on USA, Canada, France, Germany, Italy, Spain, UK, Russia, Brazil, Japan, China, India - Research and Markets

Research and Markets
Posted on: 07 Nov 17

The "Crohn's Disease Forecast in 12 Major Markets 2017-2027" report has been added to Research and Markets' offering.

This report provides the current prevalent population for Crohn's disease across 12 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Russia, Brazil, Japan, China, India) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight, several of the main symptoms and co-morbidities of Crohn's have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Crohn's disease include:

  • Gastritis and duodenitis
  • Anaemia
  • Other autoimmune diseases
  • Deep vein thrombosis
  • Skin problems: ulcers, blisters, swelling
  • Inflammation of joints

Reasons to Buy:

  • Able to quantify patient populations in global Crohn's disease's market to target the development of future products, pricing strategies and launch plans
  • Gain further insight into the prevalence of the subdivided types of Crohn's disease and identify patient segments with high potential
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries
  • Provide a level of understanding on the impact from specific co-morbid conditions on Crohn's disease's prevalent population
  • Identify sub-populations within Crohn's disease which require treatment
  • Gain an understanding of the specific markets that have the largest number of Crohn's disease patients

Key Topics Covered:

  1. Introduction
  2. Cause of the Disease
  3. Risk Factors & Prevention
  4. Diagnosis of the Disease
  5. Variation by Geography/Ethnicity
  6. Disease Prognosis & Clinical Course
  7. Key Comorbid Conditions / Features Associated With the Disease
  8. Methodology for Quantification of Patient Numbers
  9. Top-Line Prevalence for Crohn's Disease
  10. Features of Crohn's Disease Patients
  11. Associated Conditions of Crohn's Disease
  12. Abbreviations Used in the Report
  13. Other Publications
  14. Online Patient-Based Databases
  15. Patient-Based Offering
  16. Online Pricing Data & Platforms
  17. References
  18. Appendix

For more information about this report visit

View source version on

Business Wire

Last updated on: 07/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.